Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ischemic Heart Disease

  Free Subscription


1 Acta Anaesthesiol Scand
1 AJR Am J Roentgenol
4 Am Heart J
10 Am J Cardiol
1 Am J Emerg Med
4 Angiology
1 Ann Intern Med
4 Ann Thorac Surg
6 Arterioscler Thromb Vasc Biol
2 Can J Cardiol
2 Cardiovasc Res
9 Catheter Cardiovasc Interv
1 Circ Cardiovasc Imaging
4 Circ Cardiovasc Interv
2 Circ Cardiovasc Qual Outcomes
3 Circ J
3 Circulation
8 Clin Cardiol
2 Crit Care Med
14 Eur Heart J
4 Hypertension
22 Int J Cardiol
1 Int J Cardiol Hypertens
8 J Am Coll Cardiol
2 J Cardiovasc Pharmacol
1 J Clin Endocrinol Metab
1 J Electrocardiol
2 Lancet
1 Mol Cell Biochem
1 N Engl J Med
2 PLoS One
1 Thromb Haemost

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Anaesthesiol Scand

  1. WETTERSLEV M, Jacobsen PK, Hassager C, Jons C, et al
    Cardiac arrhythmias in critically ill patients with coronavirus disease 2019: A retrospective population-based cohort study.
    Acta Anaesthesiol Scand. 2021;65:770-777.
    PubMed         Abstract available

    AJR Am J Roentgenol

    Editorial Comment: ECG-Gated Aortic CTA for Characterization of Coronary Artery Involvement in Proximal Aortic Dissection Assists in Surgical Planning.
    AJR Am J Roentgenol. 2021 Jun 9. doi: 10.2214/AJR.21.26262.

    Am Heart J

  3. MONEY JE, Muhlestein JB, Mason S, Bair TL, et al
    Simplifying the ISCHEMIA Trial Algorithm for Clinical Practice: Identifying Left Main Coronary Artery Disease Using Coronary Artery Calcium Scans.
    Am Heart J. 2021 May 26. pii: S0002-8703(21)00142.
    PubMed         Abstract available

  4. BAJAJ R, Parasa R, Ramasamy A, Makariou N, et al
    Computerized technologies informing cardiac catheterization and guiding coronary intervention.
    Am Heart J. 2021 May 30. pii: S0002-8703(21)00146.
    PubMed         Abstract available

  5. COTTER G, Davison BA, Edwards C, Senger S, et al
    Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials.
    Am Heart J. 2021 Jun 6. pii: S0002-8703(21)00148.
    PubMed         Abstract available

  6. TINTUT Y, Demer LL
    Potential Impact of the Steroid Hormone, Vitamin D, on the Vasculature Vitamin D-hormones and cardiovascular disease.
    Am Heart J. 2021 May 26. pii: S0002-8703(21)00141.
    PubMed         Abstract available

    Am J Cardiol

  7. LAMPREA-MONTEALEGRE JA, Katz R, Scharnagl H, Silbernagel G, et al
    Triglyceride-Rich Lipoproteins, Apolipoproteins, and Atherosclerotic Cardiovascular Events Among Patients with Diabetes Mellitus and End-Stage Renal Disease on Hemodialysis.
    Am J Cardiol. 2021 Jun 6. pii: S0002-9149(21)00399.
    PubMed         Abstract available

  8. CASE BC, Yang M, Qamer SZ, Kumar S, et al
    Pre-Operative Cardiovascular Testing before Liver Transplantation.
    Am J Cardiol. 2021 Jun 5. pii: S0002-9149(21)00366.
    PubMed         Abstract available

  9. DAHER M, Al Rifai M, Mahtta D, Krittanawong C, et al
    Substance Use and Premature Atherosclerotic Cardiovascular Disease (From the CDC Behavioral Risk Factor Surveillance System [BRFSS] Survey).
    Am J Cardiol. 2021 Jun 5. pii: S0002-9149(21)00403.

  10. ONO M, Kawashima H, Hara H, O'Leary N, et al
    Impact of Body Composition Indices on Ten-year Mortality After Revascularization of Complex Coronary Artery Disease (From the Syntax Extended Survival Trial).
    Am J Cardiol. 2021 May 25. pii: S0002-9149(21)00361.
    PubMed         Abstract available

  11. FAN H, Zhou J, Yuan Z
    Meta-Analysis Comparing the Effect of Combined Omega-3+Statin Therapy Versus Statin Therapy Alone on Coronary Artery Plaques.
    Am J Cardiol. 2021 May 25. pii: S0002-9149(21)00367.
    PubMed         Abstract available

  12. KNIJNIK L, Fernandes M, Rivera M, Cardoso R, et al
    Meta-Analysis of Duration of Dual Antiplatelet Therapy in Acute Coronary Syndrome Treated With Coronary Stenting.
    Am J Cardiol. 2021 May 25. pii: S0002-9149(21)00368.
    PubMed         Abstract available

  13. SHAH K, Shah S, Turagam MK, Bhardwaj R, et al
    Early Implantable Cardioverter-Defibrillator After Acute Myocardial Infarction.
    Am J Cardiol. 2021 Jun 5. pii: S0002-9149(21)00400.

  14. WIENBERGEN H, Retzlaff T, Schmucker J, Marin LAM, et al
    Impact of COVID-19 Pandemic on Presentation and Outcome of Consecutive Patients Admitted to Hospital Due to ST-Elevation Myocardial Infarction.
    Am J Cardiol. 2021 Apr 27. pii: S0002-9149(21)00364.
    PubMed         Abstract available

  15. FARIDI KF, Bhalla N, Atreja N, Venditto J, et al
    New Heart Failure After Myocardial Infarction (From the National Cardiovascular Data Registries [NCDR] Linked With All-Payer Claims).
    Am J Cardiol. 2021 May 27. pii: S0002-9149(21)00373.
    PubMed         Abstract available

  16. ISOGAI T, Saad AM, Kaur M, Shekhar S, et al
    Transcatheter Mitral Valve Repair and Mitral Valve Surgery Following Acute Myocardial Infarction (Insights From a Nationwide Cohort Study).
    Am J Cardiol. 2021 Jun 7. pii: S0002-9149(21)00402.

    Am J Emerg Med

  17. WU ZC, Zhou NN, Li YX, Liu LT, et al
    Application of the SBAR communication model in the early triage of acute myocardial infarction.
    Am J Emerg Med. 2021 May 24. pii: S0735-6757(21)00439.


  18. ZHANG H, Yao J, Huang Z, Zhao Z, et al
    Prognostic Value of Baseline d-Dimer Level in Patients With Coronary Artery Disease: A Meta-Analysis.
    Angiology. 2021 Jun 3:33197211019805. doi: 10.1177/00033197211019805.
    PubMed         Abstract available

  19. YAYLA C, Yayla KG, Demirtas K
    Genome-Wide Association Studies in Patients With Coronary Artery Disease.
    Angiology. 2021 Jun 3:33197211022076. doi: 10.1177/00033197211022076.

  20. LIU X, Zhang P, Zhang J, Zhang X, et al
    The Preventive Effect of Alprostadil on the Contrast-Induced Nephropathy of Coronary Heart Disease Treated by Percutaneous Coronary Intervention in Moderate and High-Risk Population Stratified by Mehran Score.
    Angiology. 2021 Jun 8:33197211015540. doi: 10.1177/00033197211015540.
    PubMed         Abstract available

  21. ERTEM AG, Erdol MA, Demirtas K, Yayla C, et al
    Mehran Risk Score Is Still Valuable for Prediction of Contrast Nephropathy in Patients With Acute Coronary Syndrome.
    Angiology. 2021 Jun 7:33197211022093. doi: 10.1177/00033197211022093.

    Ann Intern Med

  22. TANNER M
    In type 2 diabetes, SGLT2 inhibitors reduce all-cause, but not cardiovascular, mortality vs. GLP-1 RAs.
    Ann Intern Med. 2021 Jun 1. doi: 10.7326/ACPJ202106150.
    PubMed         Abstract available

    Ann Thorac Surg

  23. BAE J, Ju JW, Lee S, Nam K, et al
    Association between abdominal fat and mortality in patients undergoing cardiovascular surgery.
    Ann Thorac Surg. 2021 Jun 8. pii: S0003-4975(21)01007.
    PubMed         Abstract available

  24. LOBO FILHO JG, Lobo Filho HG, Pimentel MD
    Composite Graft for Calcified Ascending Aorta in Coronary Artery Bypass Grafting.
    Ann Thorac Surg. 2021 Jun 5. pii: S0003-4975(21)00992.

    Toward the safer aortic root replacement in the presence of anomalous origin of coronary artery.
    Ann Thorac Surg. 2021 May 27. pii: S0003-4975(21)00904.

  26. NAITO S, Demal TJ, Sill B, Reichenspurner H, et al
    Neurological complications in high-risk patients undergoing coronary artery bypass surgery.
    Ann Thorac Surg. 2021 Jun 1. pii: S0003-4975(21)00930.
    PubMed         Abstract available

    Arterioscler Thromb Vasc Biol

  27. HAEMMIG S, Hashemi Gheinani A, Zaromytidou M, Siasos G, et al
    Novel Lesional Transcriptional Signature Separates Atherosclerosis With and Without Diabetes in Yorkshire Swine and Humans.
    Arterioscler Thromb Vasc Biol. 2021;41:1487-1503.
    PubMed         Abstract available

  28. WANJALLA CN, Mashayekhi M, Bailin S, Gabriel CL, et al
    Anticytomegalovirus CD4(+) T Cells Are Associated With Subclinical Atherosclerosis in Persons With HIV.
    Arterioscler Thromb Vasc Biol. 2021;41:1459-1473.
    PubMed         Abstract available

  29. XU () X, Xu () X, Mao () Y, Lu () L, et al
    Knockout of the NONO Gene Inhibits Neointima Formation in a Mouse Model of Vascular Injury.
    Arterioscler Thromb Vasc Biol. 2021;41:1428-1445.
    PubMed         Abstract available

  30. BUCKLER AJ, Karlof E, Lengquist M, Gasser TC, et al
    Virtual Transcriptomics: Noninvasive Phenotyping of Atherosclerosis by Decoding Plaque Biology From Computed Tomography Angiography Imaging.
    Arterioscler Thromb Vasc Biol. 2021;41:1738-1750.
    PubMed         Abstract available

  31. SAID MA, Yeung MW, van de Vegte YJ, Benjamins JW, et al
    Genome-Wide Association Study and Identification of a Protective Missense Variant on Lipoprotein(a) Concentration: Protective Missense Variant on Lipoprotein(a) Concentration-Brief Report.
    Arterioscler Thromb Vasc Biol. 2021;41:1792-1800.
    PubMed         Abstract available

  32. HOLLANDER MR, Jansen MF, Schumacher SP, Stuijfzand WJ, et al
    Coronary Collateral Flow Index Is Correlated With the Palmar Collateral Flow Index: Indicating Systemic Collateral Coherence in Individual Patients-Brief Report.
    Arterioscler Thromb Vasc Biol. 2021;41:1830-1836.
    PubMed         Abstract available


  33. Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses.
    BMJ. 2021;373:n1302.

  34. KIM D, Yang PS, You SC, Sung JH, et al
    Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study.
    BMJ. 2021;373:n991.
    PubMed         Abstract available

    Can J Cardiol

  35. LAVIE CJ, Ozemek C, Grace SL
    More Evidence of Comprehensive Cardiac Rehabilitation Benefits, Even for All-Cause Mortality: Need to Increase Use Worldwide.
    Can J Cardiol. 2021;37:19-21.

  36. HILLANI A, Potter BJ
    Intracoronary Thrombus and No-Reflow: One Size to Fit All?
    Can J Cardiol. 2021;37:202-205.

    Cardiovasc Res

  37. MAIN A, Robertson-Gray O, Fuller W
    Cyclophilin D palmitoylation and permeability transition: a new twist in the tale of myocardial ischaemia-reperfusion injury.
    Cardiovasc Res. 2021;117:15-17.

  38. PERROTTA S, Carnevale D
    A neuro-humoral activation of RAAS in endothelial dysfunction modulating immunity in heart failure.
    Cardiovasc Res. 2020 Aug 4. pii: 5880579. doi: 10.1093.

    Catheter Cardiovasc Interv

  39. BOX LC, Blankenship JC, Henry TD, Messenger JC, et al
    SCAI Position Statement on the Performance of Percutaneous Coronary Intervention in Ambulatory Surgical Centers.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28991.
    PubMed         Abstract available

  40. RUSSO JJ, Prasad M, Doshi D, Karmpaliotis D, et al
    Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28557.
    PubMed         Abstract available

  41. LEE KH, Torii S, Oguri M, Miyaji T, et al
    Reduction of door-to-balloon time in patients with ST-elevation myocardial infarction by single-catheter primary percutaneous coronary intervention method.
    Catheter Cardiovasc Interv. 2021 May 31. doi: 10.1002/ccd.29797.
    PubMed         Abstract available

  42. ALQAHTANI F, Balla S, AlHajji M, Chaudhary F, et al
    Temporal trends in the utilization and outcomes of percutaneous coronary interventions in patients with liver cirrhosis.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28593.
    PubMed         Abstract available

  43. BAWAMIA BR, Egred M, Jackson M, Purcell I, et al
    Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality.
    Catheter Cardiovasc Interv. 2020 Mar 5. doi: 10.1002/ccd.28818.
    PubMed         Abstract available

  44. LEISTNER DM, Dietrich S, Erbay A, Steiner J, et al
    Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020 Mar 6. doi: 10.1002/ccd.28839.
    PubMed         Abstract available

  45. COSGROVE C, Hanratty CG, Hill JM, Mahadevan K, et al
    Intravascular lithotripsy for treatment of calcific coronary lesions in ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29801.
    PubMed         Abstract available

  46. GRINES CL, Leach C
    Acute myocardial infarction related cardiogenic shock: How important is vascular access site?
    Catheter Cardiovasc Interv. 2021;97:1367-1368.

  47. HANNAN EL, Zhong Y, Ling FSK, Tamis-Holland J, et al
    Assessment of repeat target lesion percutaneous coronary intervention as a quality measure for public reporting and general quality assessment for PCIs.
    Catheter Cardiovasc Interv. 2019 Oct 23. doi: 10.1002/ccd.28526.
    PubMed         Abstract available

    Circ Cardiovasc Imaging

  48. SEKI K, Egi R, Sugi K, Fukushima K, et al
    Multiple Extracardiac Anastomosis of the Coronary Arteries.
    Circ Cardiovasc Imaging. 2021 Jun 4:CIRCIMAGING120012126.

    Circ Cardiovasc Interv

  49. SUTTON NR, Banerjee S, Cooper MM, Arbab-Zadeh A, et al
    Coronary Artery Disease Evaluation and Management Considerations for High Risk Occupations: Commercial Vehicle Drivers and Pilots.
    Circ Cardiovasc Interv. 2021 Jun 7:CIRCINTERVENTIONS120009950.
    PubMed         Abstract available

  50. KHALID N, Rogers T, Torguson R, Zhang C, et al
    Feasibility and Safety of High-Risk Percutaneous Coronary Intervention Without Mechanical Circulatory Support.
    Circ Cardiovasc Interv. 2021 Jun 7:CIRCINTERVENTIONS120009960.
    PubMed         Abstract available

  51. HWAN CHO J, Won H, Lee WS, Kim SW, et al
    Rapid Progression of Coronary Atherosclerosis in Patients Taking an Oral Antitumor, Multikinase Receptor Inhibitor.
    Circ Cardiovasc Interv. 2021 Jun 7:CIRCINTERVENTIONS121010705.

  52. EL HAJJ SC, Toya T, Warisawa T, Nan J, et al
    Correlation of Intravascular Ultrasound and Instantaneous Wave-Free Ratio in Patients With Intermediate Left Main Coronary Artery Disease.
    Circ Cardiovasc Interv. 2021 Jun 7:CIRCINTERVENTIONS120009830.
    PubMed         Abstract available

    Circ Cardiovasc Qual Outcomes

  53. THUESEN AL, Riber LP, Veien KT, Christiansen EH, et al
    Health-Related Quality of Life and Angina in Fractional Flow Reserve- Versus Angiography-Guided Coronary Artery Bypass Grafting: From the Randomized Fractional Flow Reserve- Versus Angiography-Guided Coronary Artery Bypass Grafting.
    Circ Cardiovasc Qual Outcomes. 2021 Jun 3:CIRCOUTCOMES120007302.
    PubMed         Abstract available

  54. MORI M, Durant TJS, Huang C, Mortazavi BJ, et al
    Toward Dynamic Risk Prediction of Outcomes After Coronary Artery Bypass Graft: Improving Risk Prediction With Intraoperative Events Using Gradient Boosting.
    Circ Cardiovasc Qual Outcomes. 2021 Jun 3:CIRCOUTCOMES120007363.
    PubMed         Abstract available

    Circ J

  55. MORIYAMA T, Fukami K
    Management of Patients With Advanced Chronic Kidney Disease and Preexisting Acute Myocardial Infarction.
    Circ J. 2021 Jun 9. doi: 10.1253/circj.CJ-21-0394.

  56. HASHIMOTO Y, Ozaki Y, Kan S, Nakao K, et al
    Impact of Chronic Kidney Disease on In-Hospital and 3-Year Clinical Outcomes in Patients With Acute Myocardial Infarction Treated by Contemporary Percutaneous Coronary Intervention and Optimal Medical Therapy- Insights From the J-MINUET Study.
    Circ J. 2021 Jun 3. doi: 10.1253/circj.CJ-20-1115.
    PubMed         Abstract available

  57. IWAHASHI N, Kirigaya J, Gohbara M, Abe T, et al
    Global Strain Measured by Three-Dimensional Speckle Tracking Echocardiography Is a Useful Predictor for 10-Year Prognosis After a First ST-Elevation Acute Myocardial Infarction.
    Circ J. 2021 Jun 1. doi: 10.1253/circj.CJ-21-0183.
    PubMed         Abstract available


  58. REYNOLDS HR, Picard MH, Spertus JA, Peteiro J, et al
    Natural History of Patients with Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.
    Circulation. 2021 Jun 1. doi: 10.1161/CIRCULATIONAHA.120.046791.
    PubMed         Abstract available

  59. KUWABARA M, Mori M, Komoto S
    Japanese National Plan for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease.
    Circulation. 2021;143:1929-1931.

  60. SELVARAJ S, Kelly DP, Margulies KB
    Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.
    Circulation. 2020;141:1800-1812.
    PubMed         Abstract available

    Clin Cardiol

  61. GAO S, Ma W, Huang S, Lin X, et al
    Predictive value of the age, creatinine, and ejection fraction score in patients with myocardial infarction with nonobstructive coronary arteries.
    Clin Cardiol. 2021 Jun 1. doi: 10.1002/clc.23650.
    PubMed         Abstract available

  62. BLANCHART K, Heudel T, Ardouin P, Lemaitre A, et al
    Glycoprotein IIb/IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre-treated with newer P2Y12 inhibitors.
    Clin Cardiol. 2021 Jun 11. doi: 10.1002/clc.23654.
    PubMed         Abstract available

  63. XIE Q, Huang J, Zhu K, Chen Q, et al
    Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary heart disease and type 2 diabetes mellitus: Cumulative meta-analysis.
    Clin Cardiol. 2021 Jun 5. doi: 10.1002/clc.23613.
    PubMed         Abstract available

  64. KUEHNEMUND L, Koeppe J, Feld J, Wiederhold A, et al
    Gender differences in acute myocardial infarction-A nationwide German real-life analysis from 2014 to 2017.
    Clin Cardiol. 2021 Jun 1. doi: 10.1002/clc.23662.
    PubMed         Abstract available

  65. NAVAR AM, Matskeplishvili ST, Urina-Triana M, Arafah M, et al
    Prospective evaluation of lipid management following acute coronary syndrome in non-Western countries.
    Clin Cardiol. 2021 Jun 5. doi: 10.1002/clc.23623.
    PubMed         Abstract available

  66. LIANG J, Zhang J, Xu Y, Teng C, et al
    Conventional cardiovascular risk factors associated with Takotsubo cardiomyopathy: A comprehensive review.
    Clin Cardiol. 2021 Jun 3. doi: 10.1002/clc.23661.
    PubMed         Abstract available

  67. ROBERTS R, Fair J
    Genetics, its role in preventing the pandemic of coronary artery disease.
    Clin Cardiol. 2021 May 25. doi: 10.1002/clc.23627.
    PubMed         Abstract available

  68. RAYNER-HARTLEY E, Wong GC, Fayowski C, Cairns JA, et al
    Impact of regionalizing ST-elevation myocardial infarction care on sex differences in reperfusion times and clinical outcomes.
    Clin Cardiol. 2021 Jun 8. doi: 10.1002/clc.23658.
    PubMed         Abstract available

    Crit Care Med

  69. KOWALEWSKI M, Zielinski K, Maria Raffa G, Meani P, et al
    Mortality Predictors in Elderly Patients With Cardiogenic Shock on Venoarterial Extracorporeal Life Support. Analysis From the Extracorporeal Life Support Organization Registry.
    Crit Care Med. 2021;49:7-18.
    PubMed         Abstract available

    Venoarterial Extracorporeal Membrane Oxygenation in Elderly Patients With Refractory Cardiogenic Shock: Is Age Truly Just a Number?
    Crit Care Med. 2021;49:156-159.

    Eur Heart J

  71. BODEN WE, Stone PH
    To stent or not to stent? Treating angina after ISCHEMIA-why a conservative approach with optimal medical therapy is the preferred initial management strategy for chronic coronary syndromes: insights from the ISCHEMIA trial.
    Eur Heart J. 2021;42:1394-1400.

  72. GERSH BJ, Boden WE, Bhatt DL, Stone PH, et al
    To stent or not to stent? Treating angina after ISCHEMIA-introduction.
    Eur Heart J. 2021;42:1387-1388.

  73. GERSH BJ, Bhatt DL
    To stent or not to stent? Treating angina after ISCHEMIA-the impact of the ISCHEMIA trial on the indications for angiography and revascularization in patients with stable coronary artery disease.
    Eur Heart J. 2021;42:1389-1393.

  74. GAUDINO M, Di Franco A, Bhatt DL, Alexander JH, et al
    The association between coronary graft patency and clinical status in patients with coronary artery disease.
    Eur Heart J. 2021;42:1433-1441.
    PubMed         Abstract available

  75. WINTHER S, Schmidt SE, Rasmussen LD, Juarez Orozco LE, et al
    Validation of the European Society of Cardiology pre-test probability model for obstructive coronary artery disease.
    Eur Heart J. 2021;42:1401-1411.
    PubMed         Abstract available

  76. SCHRODER J, Prescott E
    Coronary flow velocity reserve adds prognostic information beyond presence or absence of non-obstructive coronary atherosclerosis.
    Eur Heart J. 2021;42:1442-1443.

  77. BARTHELEMY O, Jobs A, Meliga E, Mueller C, et al
    Questions and answers on workup diagnosis and risk stratification: a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
    Eur Heart J. 2021;42:1379-1386.

  78. BARBATO E, Mehilli J, Sibbing D, Siontis GCM, et al
    Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients present
    Eur Heart J. 2021;42:1368-1378.

  79. COLLET JP, Thiele H, Barbato E, Barthelemy O, et al
    2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
    Eur Heart J. 2021;42:1289-1367.

  80. VERDECCHIA P, Angeli F, Cavallini C
    Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
    Eur Heart J. 2020 Nov 9. pii: 5964168. doi: 10.1093.

  81. RADICO F, Zimarino M, De Caterina R
    Is coronary flow velocity reserve just a marker of a higher atherosclerotic burden?
    Eur Heart J. 2021;42:1444-1445.

  82. SECHTEM U, Ong P
    Coronary stenoses in patients suspected to have obstructive coronary artery disease: the exemption rather than the rule!
    Eur Heart J. 2021;42:1412-1414.

  83. COLLET JP, Thiele H
    Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
    Eur Heart J. 2020 Nov 13. pii: 5981490. doi: 10.1093.

  84. ROY R, Koch WJ
    Adding another GRK to the fire of heart failure.
    Eur Heart J. 2020 Dec 7. pii: 6025474. doi: 10.1093.


  85. MORIKAWA N, Bancks MP, Yano Y, Kuwabara M, et al
    Serum Urate Trajectory in Young Adulthood and Incident Cardiovascular Disease Events by Middle Age: CARDIA Study.
    Hypertension. 2021 Jun 7:HYPERTENSIONAHA12117555.
    PubMed         Abstract available

  86. MINHAS AS, Ogunwole SM, Vaught AJ, Wu P, et al
    Racial Disparities in Cardiovascular Complications With Pregnancy-Induced Hypertension in the United States.
    Hypertension. 2021 Jun 8:HYPERTENSIONAHA12117104.
    PubMed         Abstract available

  87. ZHANG C, Niu K, Lian P, Hu Y, et al
    Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases.
    Hypertension. 2021;78:16-29.
    PubMed         Abstract available

  88. AIZAWA K, Casanova F, Gates PE, Mawson DM, et al
    Reservoir-Excess Pressure Parameters Independently Predict Cardiovascular Events in Individuals With Type 2 Diabetes.
    Hypertension. 2021;78:40-50.
    PubMed         Abstract available

    Int J Cardiol

  89. XU Y, Yu L, Shen C, Lu Z, et al
    Prevalence and disease features of myocardial ischemia with non-obstructive coronary arteries: Insights from a dynamic CT myocardial perfusion imaging study.
    Int J Cardiol. 2021;334:142-147.
    PubMed         Abstract available

  90. LODI RIZZINI M, Nagumo S, Gallo D, Sonck J, et al
    Mismatch between morphological and functional assessment of the length of coronary artery disease.
    Int J Cardiol. 2021;334:1-9.
    PubMed         Abstract available

  91. XIONG B, Wang Y, Liu Y, Wu C, et al
    The circulating LncRNA SNHG15/miR-346 axis may be a potential biomarker of cardiomyocyte apoptosis during myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2021;334:30.

  92. HOSHINO M, Zhang J, Sugiyama T, Yang S, et al
    Prognostic value of pericoronary inflammation and unsupervised machine-learning-defined phenotypic clustering of CT angiographic findings.
    Int J Cardiol. 2021;333:226-232.
    PubMed         Abstract available

  93. AIMO A, Pelliccia F, Panichella G, Vergaro G, et al
    Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity.
    Int J Cardiol. 2021;333:45-50.
    PubMed         Abstract available

  94. YANG C, Yang J, Fan Z, Yang J, et al
    ECs-derived exosomes: A novel therapeutic target for myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2021;333:51.

  95. ANDREOTTI F, Crea F, Patti G, Shoulders CC, et al
    Family history in first degree relatives of patients with premature cardiovascular disease.
    Int J Cardiol. 2021;333:215-218.
    PubMed         Abstract available

  96. BUCKLEY JP, Mylotte D, McEvoy JW
    Platelets and poppies: Do morphine and fentanyl differ?
    Int J Cardiol. 2021;333:43-44.

  97. DAMMAN P, Elias-Smale SE
    How is angina related to coronary microvascular dysfunction? A tip of the veil lifted.
    Int J Cardiol. 2021;334:26-27.

    Diastolic dysfunction in women with ischemia and non-obstructive coronary arteries (INOCA) - Could non-invasive imaging reveal the missing piece of the puzzle?
    Int J Cardiol. 2021;334:21-23.

  99. KOMAKI S, Ishii M, Ikebe S, Kaichi R, et al
    Association between coronary artery calcium score and stent expansion in percutaneous coronary intervention.
    Int J Cardiol. 2021;334:31-36.
    PubMed         Abstract available

  100. CLAASSENS DMF, Gimbel ME, Bergmeijer TO, Vos GJA, et al
    Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients.
    Int J Cardiol. 2021;334:10-17.
    PubMed         Abstract available

  101. DOAN TT, Molossi S, Sachdeva S, Wilkinson JC, et al
    Dobutamine stress cardiac MRI is safe and feasible in pediatric patients with anomalous aortic origin of a coronary artery (AAOCA).
    Int J Cardiol. 2021;334:42-48.
    PubMed         Abstract available

  102. SUADES R
    miRNA-346-3p/CaMKIId axis: In'DEX'ing a new pharmacological strategy for cardioprotection.
    Int J Cardiol. 2021;334:102-103.

  103. XIE MY, Hou LJ
    Dexmedetomidine down-regulates lncRNA MALAT1 to attenuate myocardial ischemia reperfusion-induced injury by increasing miR-346.
    Int J Cardiol. 2021;334:104.

  104. VERDOIA M, Barbieri L, De Luca G
    Antiplatelet therapy in ACS elderly patients: Another piece of this intriguing puzzle.
    Int J Cardiol. 2021;334:28-29.

  105. DENG J
    Advanced research on the regulated necrosis mechanism in myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2021;334:97-101.
    PubMed         Abstract available

  106. GROENLAND EH, Bots ML, Asselbergs FW, de Borst GJ, et al
    Apparent treatment resistant hypertension and the risk of recurrent cardiovascular events and mortality in patients with established vascular disease.
    Int J Cardiol. 2021;334:135-141.
    PubMed         Abstract available

  107. SACHDEVA S, Desai R, Singh S, Kumar G, et al
    Work from home culture and acute cardiovascular events: A bidirectional conundrum yet to be resolved!
    Int J Cardiol. 2021;333:250.

  108. ARISS RW, Elzanaty AM, Minhas AMK, Nazir S, et al
    Sex-based differences in clinical outcomes and resource utilization of type 2 myocardial infarction.
    Int J Cardiol. 2021 May 28. pii: S0167-5273(21)00900.
    PubMed         Abstract available

  109. LI J, Tong Y, Zhou Y, Han Z, et al
    LncRNA KCNQ1OT1 as a miR-26a-5p sponge regulates ATG12-mediated cardiomyocyte autophagy and aggravates myocardial infarction.
    Int J Cardiol. 2021 Jun 2. pii: S0167-5273(21)00910.
    PubMed         Abstract available

  110. NISHI T, Yamashita R, Imura S, Tateishi K, et al
    Deep learning-based intravascular ultrasound segmentation for the assessment of coronary artery disease.
    Int J Cardiol. 2021;333:55-59.
    PubMed         Abstract available

    Int J Cardiol Hypertens

  111. PARR SK, Steele CC, Hammond ST, Turpin VRG, et al
    Arterial stiffness is associated with cardiovascular and cancer mortality in cancer patients: Insight from NHANESIII.
    Int J Cardiol Hypertens. 2021;9:100085.
    PubMed         Abstract available

    J Am Coll Cardiol

  112. ONO M, Serruys PW, Hara H, Kawashima H, et al
    10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease.
    J Am Coll Cardiol. 2021;77:2761-2773.
    PubMed         Abstract available

  113. HUGGINS GS, Simsolo E
    Application of Mendelian Randomization to the Oxidative Modification Hypothesis.
    J Am Coll Cardiol. 2021;77:55-56.

  114. VAN SPALL HGC, Lala A, Deering TF, Casadei B, et al
    Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:2960-2972.
    PubMed         Abstract available

  115. REDFORS B, Gregson J, Ben-Yehuda O, Serruys PW, et al
    Implications of Biomarker Discordance After Coronary Artery Revascularization: The EXCEL Trial.
    J Am Coll Cardiol. 2021;77:2978-2980.

  116. MORTENSEN MB, Dzaye O, Steffensen FH, Botker HE, et al
    Prognostic Value of Coronary Artery Calcium in Symptomatic Young Individuals Age 18 to 45 Years.
    J Am Coll Cardiol. 2021;77:2980-2982.

  117. SABATINE MS, Braunwald E
    Thrombolysis In Myocardial Infarction (TIMI) Study Group: JACC Focus Seminar 2/8.
    J Am Coll Cardiol. 2021;77:2822-2845.
    PubMed         Abstract available

  118. HIRA RS
    Revascularizing Complex CAD in Elderly Patients: The Coming-of-Age Story of Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2021;77:2774-2776.

  119. ARAI AE, Bradley AJ, Sirajuddin A
    Risk Stratification for Sudden Death and Arrhythmias: A Role for Gadolinium-Enhanced CMR.
    J Am Coll Cardiol. 2021;77:42-44.

    J Cardiovasc Pharmacol

  120. WATSON K, Kukin A, Wasik AK, Shulenberger CE, et al
    Nonsteroidal Mineralocorticoid Receptor Antagonists: Exploring Role in Cardiovascular Disease.
    J Cardiovasc Pharmacol. 2021;77:685-698.
    PubMed         Abstract available

  121. LI Y, Ren X, Fang Z
    Systematic Review and Meta-analysis: The Effects of Prophylactic Proton Pump Inhibitor Treatment in Patients With Coronary Heart Disease Receiving Dual Antiplatelet Therapy.
    J Cardiovasc Pharmacol. 2021;77:835-861.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  122. BERNI TR, Morgan CL, Rees DA
    Women with Polycystic Ovary Syndrome have an increased risk of major cardiovascular events: a population study.
    J Clin Endocrinol Metab. 2021 Jun 1. pii: 6290890. doi: 10.1210.
    PubMed         Abstract available

    J Electrocardiol

  123. ESCABI-MENDOZA J, Gonzalez-Bravo DH
    Unmasking an acute coronary occlusive myocardial infarction in patients with right ventricular paced rhythm.
    J Electrocardiol. 2021;67:63-68.
    PubMed         Abstract available


  124. SOLOMON MD, Nguyen-Huynh M, Leong TK, Alexander J, et al
    Changes in Patterns of Hospital Visits for Acute Myocardial Infarction or Ischemic Stroke During COVID-19 Surges.
    JAMA. 2021 Jun 2. pii: 2780794. doi: 10.1001/jama.2021.8414.


  125. ARNETT DK
    Widespread diabetes screening for cardiovascular disease risk estimation.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)00764.

  126. PYLYPCHUK R, Wells S, Kerr A, Poppe K, et al
    Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)00572.
    PubMed         Abstract available

    Mol Cell Biochem

  127. ZHANG HA, Kitts DD
    Turmeric and its bioactive constituents trigger cell signaling mechanisms that protect against diabetes and cardiovascular diseases.
    Mol Cell Biochem. 2021 Jun 9. pii: 10.1007/s11010-021-04201.
    PubMed         Abstract available

    N Engl J Med

  128. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
    A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
    N Engl J Med. 2021;384:2014-2027.
    PubMed         Abstract available

    PLoS One

  129. TAKAGI K, Tanaka A, Yoshioka N, Morita Y, et al
    In-hospital mortality among consecutive patients with ST-Elevation myocardial infarction in modern primary percutaneous intervention era ~ Insights from 15-year data of single-center hospital-based registry ~.
    PLoS One. 2021;16:e0252503.
    PubMed         Abstract available

  130. DOMOKOS D, Szabo A, Banhegyi G, Major L, et al
    Impact of periprocedural morphine use on mortality in STEMI patients treated with primary PCI.
    PLoS One. 2021;16:e0245433.
    PubMed         Abstract available

    Thromb Haemost

  131. PEDERSEN OB, Grove EL, Kristensen SD, Nissen PH, et al
    MicroRNA as Biomarkers for Platelet Function and Maturity in Patients with Cardiovascular Disease.
    Thromb Haemost. 2021 Jun 6. doi: 10.1055/s-0041-1730375.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.